Traws Pharma, Inc.
TRAW
DELAYED 1 MONTH

9 insider filings · Latest: Mar 8, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 8, 2026Mar 10 11:22 PMTrafford ClarkeDirector
Grant/Award
33,435$1.6033,435(D)

View →

Mar 8, 2026Mar 10 11:21 PMWerner CautreelsDirector
Grant/Award
31,258$1.6031,258(D)

View →

Mar 8, 2026Mar 10 11:20 PMJohn Harold LeamanDirector
Grant/Award
33,435$1.6033,435(D)

View →

Mar 8, 2026Mar 10 11:19 PMIain D. DukesDirector, Chief Executive Officer
Grant/Award
231,336$1.60231,336(D)

View →

Mar 8, 2026Mar 10 11:18 PMCharles David PauzaChief Science Officer Virology
Grant/Award
118,367$1.60118,367(D)

View →

Mar 8, 2026Mar 10 11:17 PMNikolay SavchukDirector, Chief Operating Officer
Grant/Award
96,899$1.6096,899(D)

View →

Mar 8, 2026Mar 10 11:16 PMJack E StoverDirector
Grant/Award
33,435$1.6033,435(D)

View →

Mar 8, 2026Mar 10 11:15 PMRobert RedfieldChief Medical Officer
Grant/Award
108,854$1.60108,854(D)

View →

Mar 8, 2026Mar 10 11:12 PMMary Teresa ShoemakerDirector
Grant/Award
33,435$1.6033,435(D)

View →